BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoo JH, Holubar S, Rieder F. Fibrostenotic strictures in Crohn's disease. Intest Res 2020;18:379-401. [PMID: 32259917 DOI: 10.5217/ir.2019.09148] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Lin S, Brown JM, van Wagoner D, Fiocchi C, Rieder F. Novel mechanisms and clinical trial endpoints in intestinal fibrosis. Immunol Rev 2021;302:211-27. [PMID: 33993489 DOI: 10.1111/imr.12974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Stöss C, Berlet M, Reischl S, Nitsche U, Weber MC, Friess H, Wilhelm D, Neumann PA. Crohn's disease: a population-based study of surgery in the age of biological therapy. Int J Colorectal Dis 2021. [PMID: 33876296 DOI: 10.1007/s00384-021-03930-w] [Reference Citation Analysis]
3 Duraes LC, Lee CHA, Holubar SD. Use of Intraoperative Calibration Spheres for Endoluminal Stricture Assessment to Facilitate Heineke-Mikulicz Strictureplasty in Diffuse Stricturing Crohn's Jejunoileitis. Dis Colon Rectum 2022;65:e741-2. [PMID: 35333805 DOI: 10.1097/DCR.0000000000002360] [Reference Citation Analysis]
4 Garlatti V, Lovisa S, Danese S, Vetrano S. The Multiple Faces of Integrin-ECM Interactions in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:10439. [PMID: 34638778 DOI: 10.3390/ijms221910439] [Reference Citation Analysis]
5 Ueno A, Jijon HB, Peng R, Sparksman S, Mainoli B, Filyk A, Li Y, Wilson S, Novak K, Panaccione R, Hirota S, Dufour A, Lu C, Beck PL. Association of Circulating Fibrocytes With Fibrostenotic Small Bowel Crohn's Disease. Inflamm Bowel Dis 2021:izab157. [PMID: 34428284 DOI: 10.1093/ibd/izab157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lin XX, Qiu Y, Zhuang XJ, Liu F, Wu XM, Chen MH, Mao R. Intestinal stricture in Crohn's disease: A 2020 update. J Dig Dis 2021;22:390-8. [PMID: 34014617 DOI: 10.1111/1751-2980.13022] [Reference Citation Analysis]
7 Eun CS. Intestinal microbiota and inflammatory bowel diseases. J Korean Med Assoc 2021;64:588-95. [DOI: 10.5124/jkma.2021.64.9.588] [Reference Citation Analysis]
8 Lee YJ. Is Paradigm for the Role of Balloon-Assisted Enteroscopy Changing in Crohn's Disease? Gut Liver 2021;15:325-6. [PMID: 33988130 DOI: 10.5009/gnl210194] [Reference Citation Analysis]
9 Kim DS, Yoon J, Kim YJ, Lee JW, Hong SW, Hwang HW, Park SH, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK. Risk factors for rebleeding in Crohn's disease patients with acute severe lower gastrointestinal bleeding: With special reference to the role of anti-tumor necrosis factor therapy. J Gastroenterol Hepatol 2021. [PMID: 33734479 DOI: 10.1111/jgh.15495] [Reference Citation Analysis]
10 Liu J, Zhang L, Wang Z, Chen S, Feng S, He Y, Zhang S. Network Pharmacology-Based Strategy to Identify the Pharmacological Mechanisms of Pulsatilla Decoction against Crohn's Disease. Front Pharmacol 2022;13:844685. [PMID: 35450039 DOI: 10.3389/fphar.2022.844685] [Reference Citation Analysis]
11 Sleiman J, El Ouali S, Qazi T, Cohen B, Steele SR, Baker ME, Rieder F. Prevention and Treatment of Stricturing Crohn's Disease - Perspectives and Challenges. Expert Rev Gastroenterol Hepatol 2021;15:401-11. [PMID: 33225766 DOI: 10.1080/17474124.2021.1854732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Rada C, Gheonea D, Ţieranu CG, Popa DE. Diagnosis and Psychotherapeutic Needs by Early Maladaptive Schemas in Patients With Inflammatory Bowel Disease. Front Psychol 2021;12:807107. [PMID: 35222160 DOI: 10.3389/fpsyg.2021.807107] [Reference Citation Analysis]
13 Vedula SV, Nickerson TP, Grider DJ. A Novel Cause of Bowel Obstruction in a Patient with Long-Standing Crohn's Disease. Case Rep Pathol 2021;2021:3278392. [PMID: 34707913 DOI: 10.1155/2021/3278392] [Reference Citation Analysis]
14 Sninsky J, Barnes EL. Medical Management of Aggressive Inflammatory Bowel Disease: When Is the Time to Cut Your (and the Patient's) Losses? J Laparoendosc Adv Surg Tech A 2021;31:905-10. [PMID: 34171979 DOI: 10.1089/lap.2021.0338] [Reference Citation Analysis]
15 D'Alessio S, Ungaro F, Noviello D, Lovisa S, Peyrin-Biroulet L, Danese S. Revisiting fibrosis in inflammatory bowel disease: the gut thickens. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34876680 DOI: 10.1038/s41575-021-00543-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]